Argentina Bans Use of rBST Hormone to Align with EU Standards

On March 11, 2026, the Argentine regulatory body, Senasa, announced the prohibition of recombinant bovine somatotropin (rBST) in the nation's dairy industry. rBST, a synthetic hormone used to increase milk production in cows, has been a topic of debate regarding its safety and impact on animal welfare.

This decision brings Argentina in line with the European Union's stringent food safety regulations, which have long prohibited the use of rBST over concerns about animal health and consumer safety. The EU's stance is based on studies suggesting potential health risks associated with the hormone's use, although these claims are contested by some scientific communities.

Argentina's dairy sector is a significant component of its agricultural industry, and the ban on rBST is expected to have implications for both producers and consumers. Producers may need to adjust their practices to comply with the new regulations, potentially affecting milk yields and production costs. Consumers, on the other hand, may perceive an increase in milk prices as producers transition away from rBST.

The decision to ban rBST aligns Argentina with major dairy markets that prioritize safety and animal welfare, potentially enhancing the marketability of Argentine dairy products internationally. By adhering to EU standards, Argentina may seek to strengthen its position in the global dairy market.

Internationally, the use of rBST remains a contentious issue, with countries like the United States permitting its use under regulated conditions. The Argentine move may influence ongoing discussions and regulatory approaches in other dairy-producing nations.